paclitaxel-albumin
Showing 1 - 7 of 7
Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Pembrolizumab
- +2 more
- (no location specified)
Oct 25, 2023
Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)
Recruiting
- Esophagus Cancer
- Tislelizumab
- +2 more
-
Xiamen, Fujian, ChinaShanghaiZhongshan
Apr 8, 2023
Esophageal Squamous Cell Carcinoma, Patient-reported Outcomes, Immunotherapy Trial in Guangzhou (drug, radiation, procedure)
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
- Paclitaxel-albumin
- +5 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Nov 24, 2022
Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Toripalimab, Paclitaxel-albumin, Nedaplatin)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Toripalimab
- +4 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Oct 25, 2022
Stage IV Esophagus Squamous Cell Carcinoma Trial in Hangzhou (Camrelizumab, Irinotecan, Paclitaxel)
Not yet recruiting
- Stage IV Esophagus Squamous Cell Carcinoma
- Camrelizumab
- +5 more
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Apr 2, 2022
Stomach Tumors, Peritoneal Metastases Trial (HIPEC, Paclitaxel-albumin, Tegafur-gimeracil-oteracil potassium)
Not yet recruiting
- Stomach Neoplasms
- Peritoneal Metastases
- HIPEC
- +3 more
- (no location specified)
Oct 26, 2021
Pancreatic Cancer, Neoadjuvant Chemo Trial in Hanzhou (S1,, Paclitaxel-albumin)
Terminated
- Pancreatic Cancer
- Neoadjuvant Chemotherapy
- S1,
- Paclitaxel-albumin
-
Hanzhou, Zhejiang, ChinaZhejiang procincial people's hospital
Jan 6, 2021